RedHill Biopharma (RDHL) Operating Margin (QoQ) (2012 - 2023)
RedHill Biopharma (RDHL) Operating Margin (QoQ) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 380,088.00 |
| Mar 31, 2023 | -21,619.00 |
| Dec 31, 2022 | -63,231.00 |
| Sep 30, 2022 | -943.00 |
| Jun 30, 2022 | -7,698.00 |
| Mar 31, 2022 | 76,833.00 |
| Dec 31, 2021 | -72,195.00 |
| Sep 30, 2021 | -3,523.00 |
| Jun 30, 2021 | 2,751.00 |
| Mar 31, 2021 | -361.00 |
| Dec 31, 2020 | 2,279.00 |
| Sep 30, 2020 | 923.00 |
| Jun 30, 2020 | -155,155.00 |
| Mar 31, 2020 | 87,149.00 |
| Dec 31, 2019 | 3,723.00 |
| Sep 30, 2019 | -8,943.00 |
| Jun 30, 2019 | 26,167.00 |
| Mar 31, 2019 | -20,860.00 |
| Dec 31, 2018 | 29,766.00 |
| Sep 30, 2018 | 3,466.00 |